KB-34, a newly synthesized chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages via heme oxygenase-1 induction and blockade of activator protein-1.

Source:http://linkedlifedata.com/resource/pubmed/id/19174156

Eur. J. Pharmacol. 2009 Mar 15 606 1-3 215-24

Download in:

View as

General Info

PMID
19174156